GAMMA Investing’s Parabilis Medicines Inc PBLS Stock Holding History

GAMMA Investing’s Portfolio PBLS Stock Details PBLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$194	Buy	+6	New	+$209	﹤0.01%	4278

Other funds holding PBLS

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

GAMMA Investing's PBLS Position: Q3 2026 in Review

GAMMA Investing opened a new position in Parabilis Medicines Inc (PBLS) in Q3 2026: 6 shares worth $194. The stake represents ﹤0.01% of the portfolio and ranks #4278 among its holdings.

6 funds tracked by Wall St. Rank hold PBLS as of Q3 2026.

GAMMA Investing held 6 shares of Parabilis Medicines Inc worth $194 as of Q3 2026.
Parabilis Medicines Inc was a new GAMMA Investing position in Q3 2026.
Parabilis Medicines Inc made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4278 holding.
6 funds tracked by Wall St. Rank held Parabilis Medicines Inc as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.